Metformin Brain Side Effects Raise Questions After Scientists Find Brain 'Switch'

Metformin, a widely used diabetes medication, may lower blood sugar through a previously unrecognised pathway in the brain, according to new research. The drug is commonly prescribed to people with type 2 diabetes, a condition in which the body cannot properly regulate blood sugar levels.

Scientists said the findings suggest the drug does not act only in the liver and gut, as previously understood. Researchers at Baylor College of Medicine said the mechanism involves a protein known as Rap1 in a region of the brain called the hypothalamus.

The study, published in the journal Science Advances, examined how the drug affects brain cells involved in regulating metabolism. The findings are based on laboratory experiments and have not yet been tested in human patients. Researchers said further studies are needed to determine whether the same pathway plays a role in clinical use.

Study Identifies Brain-Based Mechanism

The research focused on the ventromedial hypothalamus, an area of the brain linked to energy balance and glucose regulation. This region helps control how the body uses and stores energy. Scientists found that metformin reduces blood sugar levels by suppressing activity in the Rap1 protein within this region.

In experiments involving mice, the drug was less effective when Rap1 was removed from specific brain cells. Other diabetes treatments continued to work, suggesting that metformin relies on this pathway in a way that differs from other medications.

Neuronal Activity Linked to Drug Response

The study also examined how metformin affects nerve cells known as SF1 neurons. These cells play a role in controlling appetite and energy use. Researchers found that the drug increased activity in these cells when Rap1 was present, indicating a connection between the protein and neuronal response.

When metformin was administered directly to the brain at very low doses, blood sugar levels in diabetic mice were reduced. The researchers said this suggests the brain may respond to lower concentrations of the drug than other parts of the body.

Vitamin B12 Deficiency

Long-term use of metformin has been associated with reduced absorption of vitamin B12, which can lead to symptoms including fatigue, memory problems and nerve-related effects. Vitamin B12 is important for maintaining healthy nerve cells and red blood cell production.

These symptoms are sometimes considered separately from the drug's direct action. Health authorities advise monitoring patients for vitamin B12 deficiency during extended treatment. Addressing low levels through supplementation may help reduce some reported symptoms.

Implications for Treatment Development

Researchers said the findings may help explain how metformin works at a biological level after decades of use. The drug has been widely prescribed for more than 60 years as a first-line treatment for type 2 diabetes.

The study authors said understanding this pathway could support the development of treatments that target similar mechanisms. They added that further research is needed to determine whether these effects apply to human patients.

Current Use and Ongoing Research

Metformin remains one of the most commonly prescribed medications for managing blood sugar levels. Its safety profile and long-term use are well-established in clinical practice.

Researchers said future studies will examine whether the brain pathway identified in the study is linked to other effects of the drug, including its potential role in ageing and neurological health.